USANA Health Sciences Inc (USNA.N)
USNA.N on New York Stock Exchange
110.50USD
12:08am IST
110.50USD
12:08am IST
Change (% chg)
$-0.80 (-0.72%)
$-0.80 (-0.72%)
Prev Close
$111.30
$111.30
Open
$111.60
$111.60
Day's High
$111.75
$111.75
Day's Low
$110.10
$110.10
Volume
21,671
21,671
Avg. Vol
48,282
48,282
52-wk High
$121.00
$121.00
52-wk Low
$52.85
$52.85
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 292.00 | 1.193 |
| FY 2017 | Dec '17 | 273.11 | 1.011 |
| Sep '17 | 261.77 | 0.967 | |
| Jul '17 | 257.06 | 0.930 | |
| Apr '17 | 255.32 | 0.855 | |
| FY 2016 | Dec '16 | 252.90 | 0.874 |
| Oct '16 | 254.22 | 1.202 | |
| Jul '16 | 258.51 | 1.034 | |
| Apr '16 | 240.45 | 0.886 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 2 | 287.82 | 288.18 | 287.46 | 291.20 |
| Quarter Ending Dec-18 | 2 | 304.52 | 308.17 | 300.88 | 295.00 |
| Year Ending Dec-18 | 2 | 1,168.88 | 1,175.00 | 1,162.77 | 1,158.55 |
| Year Ending Dec-19 | 3 | 1,227.50 | 1,263.70 | 1,170.80 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 2 | 1.06 | 1.07 | 1.05 | 1.19 |
| Quarter Ending Dec-18 | 2 | 1.20 | 1.26 | 1.13 | 1.24 |
| Year Ending Dec-18 | 2 | 4.58 | 4.60 | 4.56 | 4.74 |
| Year Ending Dec-19 | 3 | 5.15 | 5.20 | 5.11 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 15.28 | 61.77 | 40.76 | |
| P/E High - Last 5 Yrs. | 18.27 | 34.84 | 41.22 | |
| P/E Low - Last 5 Yrs. | 7.10 | 20.27 | 25.81 | |
| Beta | 1.04 | 0.75 | 0.70 | |
| Price to Sales (TTM) | 1.41 | 6.70 | 5.96 | |
| Price to Book (MRQ) | 3.79 | 5.06 | 37.68 | |
| Price to Tangible Book (MRQ) | 4.35 | 6.02 | 41.58 | |
| Price to Cash Flow (TTM) | 12.99 | 50.40 | 35.83 | |
| % Owned Institutions | 46.18 | 1.17 | 0.16 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.08 | 2.23 | |
| Dividend Yield - 5 Year Avg | -- | 1.01 | 2.51 | |
| Dividend 5 Year Growth Rate | -- | 14.00 | 9.45 | |
| Payout Ratio(TTM) | 0.00 | 40.10 | 59.21 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -0.56 | 2.16 | -1.10 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 5.67 | 5.07 | 5.13 | |
| Sales - 5 Yr. Growth Rate | 11.57 | 8.53 | 10.87 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -10.08 | 24.81 | 1.92 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 1.66 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 38.94 | 10.99 | 8.06 | |
| Capital Spending - 5 Yr. Growth Rate | 25.17 | 14.68 | 7.34 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.93 | 0.98 | 0.87 |
| Current Ratio (MRQ) | 2.44 | 1.29 | 1.50 |
| LT Debt to Equity (MRQ) | 0.00 | 23.01 | 7.64 |
| Total Debt to Equity (MRQ) | 0.00 | 30.90 | 18.61 |
| Interest Coverage (TTM) | -- | 133.60 | 39.43 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 82.55 | 55.83 | 38.59 | |
| Gross Margin - 5 Yr. Avg. | 82.27 | 45.04 | 37.45 | |
| EBITD Margin (TTM) | 14.45 | -- | -- | |
| EBITD - 5 Yr. Avg | 16.20 | 13.34 | 19.81 | |
| Operating Margin (TTM) | 13.04 | 13.72 | 18.28 | |
| Operating Margin - 5 Yr. Avg. | 14.98 | 11.32 | 18.04 | |
| Pre-Tax Margin (TTM) | 13.15 | 13.87 | 18.37 | |
| Pre-Tax Margin - 5 Yr. Avg. | 14.99 | 11.87 | 17.65 | |
| Net Profit Margin (TTM) | 9.47 | 10.32 | 13.71 | |
| Net Profit Margin - 5 Yr. Avg. | 10.21 | 8.61 | 13.09 | |
| Effective Tax Rate (TTM) | 27.95 | 25.73 | 25.71 | |
| Effective Tax Rate - 5 Yr. Avg. | 31.87 | 21.66 | 25.78 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 570,194 | 14,971,103 | 4,194,806,768 | |
| Net Income/Employee (TTM) | 54,025 | 1,437,887 | 606,384,815 | |
| Receivable Turnover (TTM) | -- | 8.70 | 18.28 | |
| Inventory Turnover (TTM) | 2.54 | 2.81 | 6.17 | |
| Asset Turnover (TTM) | 2.18 | 0.81 | 1.78 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 20.67 | 7.26 | 25.25 | |
| Return on Assets - 5 Yr. Avg. | 23.59 | 13.47 | 29.11 | |
| Return on Investment (TTM) | 28.79 | 10.62 | 62.30 | |
| Return on Investment - 5 Yr. Avg. | 33.05 | 24.58 | 64.39 | |
| Return on Equity (TTM) | 29.40 | 15.26 | 73.91 | |
| Return on Equity - 5 Yr. Avg. | 34.54 | 31.06 | 73.23 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 9.54 | 11.89 | 11.57 |
| EPS (TTM) % | 11.19 | 12.82 | 38.94 |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for USANA Health Sciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.90 | -1.61 | 99 | 7 |
| 13 Week | -7.01 | -11.54 | 50 | 17 |
| 26 Week | 4.33 | -3.60 | 99 | 58 |
| 52 Week | -17.98 | -30.48 | 42 | 24 |
| YTD | -3.59 | -15.34 | 53 | 45 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 50.54% |
| # of Holders: | 255 |
| Total Shares Held: | 12,218,434 |
| 3 Mo. Net Change: | 21,820 |
| # New Positions: | 8 |
| # Closed Positions: | 5 |
| # Increased Positions: | 18 |
| # Reduced Positions: | 12 |
| # Net Buyers: | 6 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.